127 results on '"Olesiński, Tomasz"'
Search Results
2. Which tumour factors preclude organ preservation in patients with rectal cancer?
3. The molecular network of the proteasome machinery inhibition response is orchestrated by HSP70, revealing vulnerabilities in cancer cells
4. Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies
5. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
6. The gentamicin-collagen implant and the risk of distant metastases of rectal cancer following short-course radiotherapy and curative resection: the long-term outcomes of a randomized study
7. Evaluation of the incidence of splenic hilar lymph node metastasis in patients operated on for esophagogastric junction cancer
8. Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer
9. IL-1β and IL-6 as predictors of ypN and early response to neoadjuvant chemotherapy in patients with locally advanced GC and GEJ cancer.
10. Individualized surgical treatment in patients with advanced gastrointestinal stromal tumor -- a case series.
11. The influence of surgery quality on the longtime results of gastric cancer combination therapy
12. 2072: Radiation boost to the enlarged lateral nodes in patients receiving radiotherapy for rectal cancer
13. Safety and efficacy of the FLOT regimen in the Polish population - an analysis of the prospective trial
14. The response network of HSP70 defines vulnerabilities in cancer cells with the inhibited proteasome
15. The surgical treatment of rectal cancer in Poland. The findings of a multi-center observational study by the Polish Society of Surgical Oncology (PSSO-01)
16. Does epidural analgesia modify the risk of complications after gastrectomy?
17. Long noncoding RNA CCAT1 rs67085638 SNP contribution to the progression of gastric cancer in a Polish population
18. Pankreatomia jako forma leczenia przerzutu mięśniakomięsaka gładkokomórkowego- opis przypadku i przegląd literatury
19. Long-term results of randomized studies on the use of a gentamicin-collagen sponge in rectal cancer – depending on the length of time between the completion of radiotherapy and the surgery
20. GWAS Links New Variant in Long Non-Coding RNA LINC02006 with Colorectal Cancer Susceptibility
21. The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice
22. Guidelines from the Polish Surgical Society and Polish Society of Oncological Surgery Concerning Quality Assurance for Centres Performing Cytoreductive Procedures and HIPEC Procedures in the Treatment of Primary and Secondary Peritoneal Tumours
23. Guidelines of the Association of Polish Surgeons and the Polish Society of Surgical Oncology on the accreditation of healthcare centers providing cytoreductive surgery and HIPEC for primary and secondary peritoneal cancers
24. Wpływ radiochemioterapii na odległą jakość życia chorych leczonych operacyjnie z powodu raka żołądka.
25. Odległe następstwa metaboliczne leczenia przyczynowego raka żołądka.
26. Renal cell carcinoma metastasis to neuroendocrine pancreas tumor: case report and literature review
27. Long-term survival after surgical resection of locoregional gastric adenocarcinoma recurrence — a case report
28. Pancreatectomy as a form of treatment for leiomyosarcoma metastasis to pancreas -- case report and literature review.
29. Surgical treatment of rectal cancer in Poland — a report from a prospective, multi-centre observational study PSSO_01 conducted under the auspices of the Polish Society of Surgical Oncology
30. Fungal Infections in the Intensive Care Unit – empiric therapy with echinocandins in patients with faecal peritonitis may improve the survival rate twofold
31. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
32. Conventional cytology vs. immunocytochemistry of intraoperative peritoneal washes in gastric cancer patients subjected to gastrectomy: clinical correlates and association with overall survival
33. Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.
34. Bezpieczeństwo personelu medycznego biorącego udział w procedurze dootrzewnowej chemioterapii perfuzyjnej w hipertermii
35. Long-term survival of gastric cancer patients with positive immunocytochemistry peritoneal washings.
36. Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases of sarcomas and other rare malignancies
37. Utility of nutritional evaluation for the clinical risk assessment of postoperative complications. Does oncology need the NRS 2002 scale?
38. The risk of anastomotic leakage after anterior resection: retrospective analysis of 501 rectal cancer patients operated without protective stoma
39. Preservation of duodenal passage as a determinant of short- and long-term quality of life in gastric cancer patients after total gastrectomy
40. Prospective monitoring of the early treatment results of the GI tract tumours at the Oncology Centre in Warsaw
41. Surgical treatment of gastric cancer: then and now
42. The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study
43. Su1308 - CT is Better than Small Bowel Endoscopy as a Diagnostic Tool Leading to Surgery in Patients with Small Bowel Tumors - Retrospective Evaluation in Tertiary Referral Centre
44. Metastatic tumors of pancreas -- whether and when surgical intervention is gainful for diseased people. Retrospective analysis of data from three surgery centers.
45. Diagnostics and treatment of small intestine tumors in our own experience.
46. Splenic artery aneurysm bleeding via the ampulla of Vater
47. Brunneroma — rzadka przyczyna niedrożności i krwawienia do przewodu pokarmowego — opis przypadku
48. P-136 - Prolonged enteral nutrition after total gastrectomy due to cancer: Phase III study
49. P-135 - The role of serum tumour markers, inflammation-based markers and circulating tumour cells as surrogate biomarkers of early response to neoadjuvant systemic treatment in patients with resectable gastric cancer.
50. Prognostyczne czynniki ryzyka nieszczelności zespolenia po resekcji przedniej u chorych na raka odbytnicy: kiedy zabezpieczająca stomia jest rzeczywiście potrzebna? Przegląd piśmiennictwa omawiającego 15 457 chorych
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.